Hyperfine, a company attempting to “redefine” brain imaging with its US Food and Drug Administration (FDA)-cleared, artificial intelligence (AI)-powered portable magnetic resonance (MR) solution—the Swoop system—recently announced a strategic collaboration with technology giant NVIDIA.
As per a Hyperfine press release, this collaboration leverages NVIDIA’s AI expertise and accelerated computing to enhance Hyperfine’s portable imaging technology—making brain MR imaging (MRI) faster, smarter, and more affordable on a global scale.
Hyperfine states that its goal is to transform the current paradigm whereby 90% of the global population lacks access to timely MRI diagnostics due to the high cost and infrastructure demands of conventional MRI systems. The company’s AI-powered portable MR technology is designed for use at the point of care in professional healthcare settings by any trained clinician, and “addresses critical healthcare gaps that conventional MRI systems cannot fill”.
The recently announced collaboration between Hyperfine and NVIDIA will focus on advancing AI-powered image reconstruction and embedding real-time clinical decision support into portable MRI workflows. By leveraging the NVIDIA advanced suite of training and inference tools—such as its Data loading library (DALI) and Medical open network for AI (MONAI)—the collaboration seeks to further improve the Swoop system’s image quality, reduce scan times, and enable faster, more reliable diagnoses.
“Our mission is to make portable brain imaging faster, more intelligent, and increasingly accessible—ultimately improving health outcomes and reducing costs globally,” said Maria Sainz, president and chief executive officer (CEO) of Hyperfine. “Partnering with NVIDIA presents an incredible opportunity to advance and accelerate our AI technology. I’m thrilled about the possibilities this collaboration brings for the future.”
